Delivery Order SPE2DB24D2011-SPE2DB25FBQRZ

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for 4,566,319,480 units of the nasal spray medication VALTOCO 10 MG, with a ceiling value of $1,658.10. The delivery order is a firm fixed price contract with a completion date of November 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,654.29, is for the delivery of 4,568,060,888 units of the drug VALTOCO 10 MG NASAL SPRAYS. The contract is a firm fixed-price delivery order with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $5,018.20 to provide 4,565,372,771 units of the prescription nasal spray medication VALTOCO 15 MG. The order has a firm fixed price and an ultimate completion date of August 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other agencies to supply critical medical supplies and pharmaceuticals,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,118,789 units of VALTOCO 10 MG NASAL SPRAYS, with a ceiling value of $2,259.24. The contract is a firm fixed-price delivery order with a period of performance through May 5, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,568,072 units of the pharmaceutical product VALTOCO 10 MG NASAL SPRAYS. The contract has a ceiling value of $2,259.24 and a period of performance through April 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $2,018.28 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of VALTOCO 10 MG NASAL SPRAYS, a critical care medication, with an ultimate completion date of August 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,128.54, is for the supply of 4,568,142,640 units of the nasal spray medication VALTOCO 15 MG. The contract has an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. The contract is not set aside for any...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a value of $2,707.80 and is for the delivery of VALTOCO 20 mg nasal sprays. The order is a firm fixed-price contract with a completion date of January 23, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,504,080 units of VALTOCO 20 MG Nasal Sprays, a pharmaceutical product. The order has a ceiling value of $1,016.66 and a completion date of August 20, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans'...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VALTOCO 15 MG nasal sprays. The firm-fixed-price contract, valued at $1,253.64, has a period of performance through June 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a wide...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB25FBQRZ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,143,228 units of the nasal spray medication VALTOCO 15 MG. The contract has a firm fixed price of $2,198.09 and a period of performance ending on May 6, 2025.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and represents one of many orders the company fulfills to supply diverse medical products, including prescription medications, medical devices, and specialized supplies, to various government agencies, particularly supporting military and veteran healthcare programs.

Generated 8/4/25, 9:47 AM